Skip to main content Skip to navigation
We care about your privacy. Read about your rights and how we protect your data. Get Details

Coronavirus Update:What patients and families need to know

Education & Training

  • Fellowship Program, Pediatric Hematology/Oncology, 2012
    Johns Hopkins/NCI
  • Residency Program, Pediatrics, 2008
    Johns Hopkins Hospital
  • Internship Program, Pediatrics, 2006
    Children's Hospital of Michigan
  • MPH, 2005
    University of Massachusetts
  • MBBS, 2003
    Lokmanya Tilak Municipal Medical Center
  • BS, 1997
    University of Mumbai

Board Certifications

  • American Board of Pediatrics
  • American Board of Pediatrics/Hematology-Oncology

National Provider ID: 1124168208


Hema Dave, M.D., M.P.H., is an oncologist in the Division of Oncology at the Center for Cancer and Blood Disorder at Children's National Hospital. She joined Children's National in 2012. She is a physician scientist in the Cell Enhancement and Technologies Institute (CETI) Laboratory at the Center for Cancer Immunology Research at CNRI. She is an assistant professor on the tenure track at the George Washington School of Medicine. She received her medical degree from the University of Mumbai, India, completed residency in pediatrics from The Johns Hopkins Hospital and fellowship in Pediatric Hematology/Oncology from the combined program at Johns Hopkins Hospital and the National Cancer Institute (Experimental Transplantation and Immunobiology Branch).

Dr. Dave's research interests are in T cell immunotherapies and hematologic malignancies. She is a translational investigator and currently conducting immunobiology correlative studies in patients with high risk Hodgkin Lymphoma enrolled on a large multi-institutional trial through the Children’s Oncology Group. She serves as a principal investigator and co-investigator on many T cell therapy trials at Children's National. She also serves as the clinical director for the commercial chimeric antigen receptor T cell therapy program and is the institutional PI for industry sponsored CAR-T trial for Non-Hodgkin Lymphoma. She has received career development awards from the American Society of Hematology and the Lymphoma Research Foundation. Her goal is to advance novel immunotherapies to the clinic to improve the outcomes of children with leukemia/lymphoma.

She lives in Silver Spring, MD with her husband and daughter and enjoys hiking and camping in the National Parks and running.

Research & Publications

Selective cell surface expression of receptor tyrosine kinase ROR1 in pediatric acute lymphoblastic leukemia suggests targetability with monoclonal antibody based therapies

(2012) PLoS One

Immunotherapy for Pediatric Leukemia

(2013) Frontiers in Oncology

The Role of Screening sinus CT in pediatric hematopoietic stem cell transplant recipients

(2014) Journal of Computed Tomography